Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

576 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission during the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study using Genomic Epidemiology.
Banga J, Brock-Fisher T, Petros BA, Dai EY, Leonelli AT, Dobbins ST, Messer KS, Nathanson AB, Capone A, Littlehale N, Appiah-Danquah V, Dim S, Moreno GK, Crowther M, Lee KA, DeRuff KC, MacInnis BL, Springer M, Sabeti PC, Stephenson KE. Banga J, et al. Among authors: capone a. medRxiv [Preprint]. 2024 Feb 7:2024.02.05.24302348. doi: 10.1101/2024.02.05.24302348. medRxiv. 2024. PMID: 38370621 Free PMC article. Preprint.
Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir.
Dai EY, Lee KA, Nathanson AB, Leonelli AT, Petros BA, Brock-Fisher T, Dobbins ST, MacInnis BL, Capone A, Littlehale N, Boucau J, Marino C, Barczak AK, Sabeti PC, Springer M, Stephenson KE. Dai EY, et al. Among authors: capone a. medRxiv [Preprint]. 2022 Aug 4:2022.08.04.22278378. doi: 10.1101/2022.08.04.22278378. medRxiv. 2022. PMID: 35982651 Free PMC article. Preprint.
Phase I trial of viral vector based personalized vaccination elicits robust neoantigen specific antitumor T cell responses.
D'Alise AM, Leoni G, Cotugno G, Siani L, Vitale R, Ruzza V, Garzia I, Antonucci L, Micarelli E, Venafra V, Gogov S, Capone A, Runswick S, Martin-Liberal J, Calvo E, Moreno V, Symeonides SN, Scarselli E, Bechter O. D'Alise AM, et al. Among authors: capone a. Clin Cancer Res. 2024 Mar 20. doi: 10.1158/1078-0432.CCR-23-3940. Online ahead of print. Clin Cancer Res. 2024. PMID: 38506710
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Brown DM, Boyer DS, Do DV, Wykoff CC, Sakamoto T, Win P, Joshi S, Salehi-Had H, Seres A, Berliner AJ, Leal S, Vitti R, Chu KW, Reed K, Rao R, Cheng Y, Sun W, Voronca D, Bhore R, Schmidt-Ott U, Schmelter T, Schulze A, Zhang X, Hirshberg B, Yancopoulos GD, Sivaprasad S; PHOTON Investigators. Brown DM, et al. Lancet. 2024 Mar 23;403(10432):1153-1163. doi: 10.1016/S0140-6736(23)02577-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461843 Clinical Trial.
Endovascular aneurysm repair under local anesthesia through bilateral percutaneous femoral access is a safe strategy to improve early outcomes and reduce hospital stay.
Esposito D, Fargion AT, Dorigo W, Melani C, Mauri F, Zacà S, Pratesi G, Piffaretti G, Angiletta D, Pratesi C, Pulli R; Italian Collaborators for EVAR (ICE) Group. Esposito D, et al. Int Angiol. 2024 Apr;43(2):262-270. doi: 10.23736/S0392-9590.24.05134-4. Epub 2024 Mar 8. Int Angiol. 2024. PMID: 38454886
Pragmemes revisited. A theoretical framework.
Capone A, Graci R. Capone A, et al. Front Psychol. 2024 Jan 31;15:1329291. doi: 10.3389/fpsyg.2024.1329291. eCollection 2024. Front Psychol. 2024. PMID: 38356773 Free PMC article. Review.
576 results